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and Learning: Regulation by
Noradrenaline, Serotonin and ATP
Marie E. Gibbs*
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia
This paper reviews the role played by glycogen breakdown (glycogenolysis) and
glycogen re-synthesis in memory processing in two different chick brain regions, (1) the
hippocampus and (2) the avian equivalent of the mammalian cortex, the intermediate
medial mesopallium (IMM). Memory processing is regulated by the neuromodulators
noradrenaline and serotonin soon after training glycogen breakdown and re-synthesis.
In day-old domestic chicks, memory formation is dependent on the breakdown of
glycogen (glycogenolysis) at three specific times during the first 60 min after learning
(around 2.5, 30, and 55 min). The chicks learn to discriminate in a single trial
between beads of two colors and tastes. Inhibition of glycogen breakdown by the
inhibitor of glycogen phosphorylase 1,4-dideoxy-1,4-imino-D-arabinitol (DAB) given at
specific times prior to the formation of long-term memory prevents memory forming.
Noradrenergic stimulation of cultured chicken astrocytes by a selective β2-adrenergic
(AR) agonist reduces glycogen levels and we believe that in vivo this triggers memory
consolidation at the second stage of glycogenolysis. Serotonin acting at 5-HT2B
receptors acts on the first stage, but not on the second. We have shown that
noradrenaline, acting via post-synaptic α2-ARs, is also responsible for the synthesis
of glycogen and our experiments suggest that there is a readily accessible labile pool
of glycogen in astrocytes which is depleted within 10 min if glycogen synthesis is
inhibited. Endogenous ATP promotion of memory consolidation at 2.5 and 30 min is
also dependent on glycogen breakdown. ATP acts at P2Y1 receptors and the action of
thrombin suggests that it causes the release of internal calcium ([Ca2+]i) in astrocytes.
Glutamate and GABA, the primary neurotransmitters in the brain, cannot be synthesized
in neurons de novo and neurons rely on astrocytic glutamate synthesis, requiring
glycogenolysis.
Keywords: astrocytes, glycogen re-synthesis, noradrenaline, ATP, serotonin, memory processing, consolidation,
day-old chickens
INTRODUCTION
The major fuel for all cells in the brain is glucose and both astrocytes and neurons metabolize
glucose via glycolysis and oxidative phosphorylation. Neuronal transmission of information
is undoubtedly important for memory but astrocytes are also critically involved in memory
processing. Memory is dependent on metabolic functions including Na/K-ATPase activity and
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glucose uptake, which occur in both neurons and astrocytes.
It is also reliant on glycogen breakdown and re-synthesis. It
is recognized that glycogen has an important role in the brain
(e.g., Brown, 2004; Brown and Ransom, 2007; Hertz et al.,
2007; Oz et al., 2007; Morgenthaler et al., 2009). Normally
only astrocytes can store glucose as glycogen. Glycogen in the
brain is stable and has slow turnover under resting conditions
(Watanabe and Passonneau, 1973; Choi et al., 2003; Oz et al.,
2007). Glycogen is unlikely to be acting solely as a slowly
available energy source. The breakdown of glycogen increases
substantially during sensory activation in the brain (Swanson,
1992; Swanson et al., 1992; Cruz and Dienel, 2002) and it
appears to have an active role in astrocytic function. It is
necessary for memory formation in both chickens and rodents
(O’Dowd et al., 1994; Gibbs et al., 2006; Suzuki et al., 2011;
Newman et al., 2011; Duran et al., 2013). Both Suzuki et al.
and Newman et al. assumed that glycogen-derived lactate is used
as a metabolic fuel by neurons after release from astrocytes via
the astrocytic monocarboxylate transporters MCT 1 and 4 and
uptake in neurons via the neuronal MCT 2 (i.e., operation of the
astrocyte-to-neuron lactate shuttle (ANLS)) suggested by Pellerin
et al. (1998) and Pellerin and Magistretti (2012). However, a
recent study by Tadi et al. (2015) showed that learning in mice
increased expression of MCT 1 and 4 without aﬀecting MCT 2.
Thus astrocytic lactate release is important for learning but
it is doubtful whether any neuronal uptake occurs. Moreover
convincing evidence has recently been obtained for activity-
dependent glucose phosphorylation in neurons (Patel et al.,
2014), which focuses attention on recently discovered signaling
functions of extracellular lactate (Tang et al., 2014; Bergersen,
2015). In this context it is interesting that the lactate signaling
demonstrated by Tang et al. (2014) like memory in the chicken
is abolished not only by the glycogenolysis inhibitor DAB (see
below) but also by D-lactate (Gibbs and Hertz, 2008). The action
of these and other drugs used in the studies to be reviewed are
summarized in Table 1.




The experiments described in this review use avoidance training
in the day-old chick. Chicks are precocious and can discriminate
between colors soon after hatch, and they do so after a single
10 s learning experience. At training a red bead is tainted with
a compound of bitter taste (methyl anthranilate) and presented
to the chick for 10 s. They peck at this bead once or twice
(Figure 1A) before registering the bitter taste and turning away
in disgust (Figure 1B). On test after a predetermined interval
they are then presented with clean red (Figure 1C) and blue
(Figure 1D) beads, each for 10 s. The chickens will avoid
the second (untainted) red bead when presented, but they will
continue to peck when presented with a neutral blue bead.
Memory is measured as the ratio of pecks at red and blue beads
on test. A high discrimination ratio reﬂects a good memory and
avoidance of pecking at the red bead, whereas a discrimination
ratio close to 0.5 reﬂects an increased rate of pecking at the red
bead- such that red and blue beads are pecked at equally on the
10 s test (for details see Gibbs and Summers, 2002a; Gibbs et al.,
2008d). It is not uncommon for chicks to give up to 10 pecks at
the blue bead, and when they have forgotten they can give up to
10 pecks on the clean red bead.
The chicks are kept in pairs and used in groups of 20, or
more recently, in groups of 16 chicks. The data from chicks not
pecking the blue bead on test or not pecking the red bead on
training are excluded from the data analysis at the completion
of the experiment. Each data point on the behavioral graphs
represents a single group of chicks with generally no more than
2–3 chicks excluded on the basis on not training or avoiding the
blue bead, i.e., N ≥ 13–14 when the original number in the group
was 16. The very short training period enables exact timing of
biochemical events correlated with learning.
The bead is either strongly aversive, i.e., the bitter taste is
caused by application of 100% anthranilate, or weakly aversive
when anthranilate is diluted to 20% with alcohol. When separate
groups of chicks are tested at deﬁned periods post-training
after strongly reinforced training three stages of memory are
revealed, and the memory remains for days, indicating that
this corresponds to normal learning. However, even in normal
learning there are brief periods of low discrimination ratios
measured on testing at 15 or at 55min. With weak reinforcement,
with the exception of the test at 15min after training, the memory
is good on tests up to 30 min after which memory disappears
(Figure 1E).
Based on the demonstration of diﬀerent biochemical events
(Gibbs and Ng, 1977) we have deﬁned three stages of memory
consolidation during normal learning : short-term (STM)-lasting
for 10 min intermediate term memory (ITM), which has two
diﬀerent stages, ITMA between 20 and 30 min and ITMB
between 30 and 50 min. The transition is normally triggered
by neuromodulatory transmitters, including noradrenaline and
serotonin, as will be reviewed here. Weakly reinforced learning
(Figure 1E) includes ITMA but not ITMB, another indication
that these two stages depend upon diﬀerent metabolic events.
The advantage of studying weakly reinforced learning is that it
can be converted to normal learning by diﬀerent procedures,
providing information on possible underlying mechanisms.
Normal learning can on the other hand be disrupted by other
interventions, again providing clues about the underlying events.
Accordingly, both types of learning will be discussed in this
review.
Drugs are injected into the hippocampus in 1 μl volumes
(Gibbs et al., 2008a; Figure 1F) or in 5 or 10 μl volumes into the
intermediate medial mesopallium (IMM), a cortical integration
area in the avian brain serving the same functions as the cortex
in mammals (Puelles et al., 2000; Reiner et al., 2004; Jarvis
et al., 2005). This area of the brain has been traditionally used
for studies on memory (see Gibbs, 2008; Gibbs et al., 2008d).
By injecting diﬀerent groups of chicks at diﬀerent times, we
have been able to determine when memory is vulnerable to
either inhibition in the case of strongly reinforced training or
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TABLE 1 | Individual effects of drugs on glycogenolysis and memory in imm and hippocampus (Hp).
Receptor agonists
ARC239 α2C-AR agonistActivates glycogen synthesis IMM and HP
RO363 β2-AR agonist consolidates ITMA HP not IMM
Zinterol β2-AR agonist consolidates ITMB Activates glycogenolysis IMM and HP
CL316243 β3-AR agonist consolidates ITMA IMM and HP
5-HT Serotonin, an agonist on many subtypes, activates glycogenolysis, but probably not glycogen synthesis IMM, HP unknown
Fluoxetine 5-HT2B agonist IMM, HP unknown
Paroxetine 5-HT2B agonist IMM, HP unknown
ATP ATP receptor agonist, promotes consolidation 2.5 and 30 and 35 min after training IMM and HP
ADP| 3S P2Y1 receptor agonist, promotes consolidation 2.5 and 35 min after training HP
ATPγS P2Y2 receptor agonist, promotes consolidation 2.5 and 30 min after training HP
Thrombin Stimulates release of internal calcium ([Ca2+ ]i ) in astrocytes, promotes consolidation 2.5 and 35 min after training IMM and HP
Phaclofen GABAB receptor antagonist inhibits memory during STM and ITMA injected up to 25 min after training IMM and HP
Receptor antagonists
CGP20712A β1-ARs, antagonist inhibits STM HP not IMM
ICI118551 β2-AR antagonist inhibits ITMB IMM and HP
SR59230A β3-AR antagonist inhibits ITMA IMM and HP
SB221284 5-HT2B/C R antagonist inhibits STM and ITMB IMM HP unknown
MRS2179 P2Y1 receptor antagonist, inhibits consolidation 2.5 and 35 min after training STM and HP
D-AVP NMDA receptor antagonist, inhibits 2.5 and 30 min after training IMM and HP
Metabolic inhibitors
DAB Inhibits glycogenolysis IMM and HP
Fluoroacetate Inhibits astrocytic oxidative metabolism and memory during STM and ITMA injected up to 20 min after training IMM and HP
consolidation in the case of weakly reinforced training. When
injections of inhibitory agents are made after strongly reinforced
training, memory is poor on test either at 120 min or at speciﬁed
times after training; consolidation of weakly reinforced training
maintains memory after ITMA. Figure 1F shows details of the
injection procedure for hippocampal injections and it can be seen
that tissue damage due to the injection is minimal (Gibbs et al.,
2008a). All procedures reviewed here have been approved by the
Monash University Animal Ethics Committee and comply with
the 1997 Australian Code of Practice for the care and use of
animals for scientiﬁc purposes. All eﬀorts were made to minimize
both the suﬀering and the number of animals used. Chicks were
killed at the completion of each experiment by CO2 inhalation.
Key points of our ﬁndings are (1) the involvement of
glycogen in memory processing and in synthesis of glutamate, a
neurotransmitter essential for learning (Riedel et al., 2003) and
long-term potentiation, LTP (Bashir et al., 1993), (2) the role
of neuromodulators in glycogenolysis, glycogen synthesis and
learning, and (3) mechanisms by which the neuromodulators
inﬂuence glycogen storage and breakdown and thus the processes
during learning which are glycogenolysis-dependent. A crucial
role of glycogenolysis in glutamate synthesis (Figure 2) was
ﬁrst shown in chick brain during learning (Gibbs et al., 2007)
and its role in support of glutamatergic transmission was
conﬁrmed in co-cultures of neurons and astrocytes (Sickmann
et al., 2009) and in the mouse brain (Sickmann et al., 2012).
That synthesis of transmitter glutamate as well as return of
previously released transmitter glutamate depends on astrocytic
metabolism has been known for a long time (reviewed by
Gibbs et al., 2008b; Hertz, 2013; Hertz and Rothman, 2015),
however that the astrocytic-neuronal ﬂux carrying glutamate
from astrocytes to neurons equals the rate of total neuronal
glucose consumption (or 75% of total gray matter oxygen uptake)
has only been established more recently (Sibson et al., 1998;
Rothman et al., 2011). This shows the intensity of the astrocytic-
neuronal interactions required during learning.
MEMORY FORMATION REQUIRES THE
BREAKDOWN OF GLYCOGEN
Measurement of the change in glycogen levels, expressed as %
of pretraining levels revealed two periods where total forebrain
levels decreased and later rose to former pretraining levels
(O’Dowd et al., 1994; Hertz et al., 2003). There is a large, rapid
decrease 2.5 min after training where glycogen levels remain
low for 10 min and then return to previous levels within 5 min
(Figure 3A). There is a second transient decrease at 55 min.
This ﬁts wth the turnover of brain glycogen increasing during
activation of brain tissue (Swanson et al., 1992; Dienel et al.,
2003, 2007). A third tendency toward a decrease at 30 min is not
signiﬁcant.
The importance of the breakdown of glycogen for learning is
seen when an inhibitor of glycogenolysis or glycogen breakdown
is injected into the forebrain at diﬀerent times after training. The
glycogen phosphorylase inhibitor DAB (Andersen et al., 1999;
Fosgerau et al., 2000) blocks glycogenolysis but is known not to
aﬀect glycolysis.
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FIGURE 1 | Memory model established from single trial learning in day-old chicks. Prior to training chicks are presented once with clean red and blue beads
to ensure they will peck at beads of both colors. For training they are presented for 10 sec with a red bead lightly coated in methyl anthranilate (A). They peck at this
once or twice before registering the bitter taste and turning away in disgust (B). On test they are then presented with clean red (C) and blue (D) beads, each for 10 s
and the number of pecks on each counted using an electronic counter and converted by computer to discrimination ratios (DRs). Perfect learning equals a DR of 1,
and complete forgetting or inhibition of learning a DR of 0.5. Normally the DR after unimpaired learning is ∼0.9. The chicks are kept in pairs and 8–10 pairs are
included in the group used in each experiment, which allows reliable determination of significance. Each data point on subsequent graphs represents one group.
(E) Memory stages following strongly reinforced (red line) after exposure to undiluted aversant and weakly reinforced training (green line) after exposure to diluted
aversant. The loss of labile, weakly reinforced memory coincides with the transition between two phases of intermediate memory (ITM A and B) 30 min post-training.
Drugs are used to inhibit strongly reinforced learning or rescue weakly reinforced learning, as indicated by memory retained 120 min after training. (F) Illustration of
injection for hippocampal administration of drugs. (a) Image of head with scull removed and injection site indicated by arrowhead. Dotted line indicates coronal
section presented in panels (b) and (c). see Gibbs et al., 2008a for details. (1F from Gibbs et al., 2008a).
In chicks where DAB was injected into IMM 5 min before
training or 55 min after training, there was very poor memory
2 h later, but injection between 25 and 45 min after training
also decreased memory (Figure 3B). When does this memory
deﬁcit occur? The early blockade of glycogenolysis 5 min prior
to training leads to an inability to retrieve memory from short-
term storage until after 10 min after training, with no amnestic
eﬀect being seen between 20 and 30 min (Figure 3C); we
concluded therefore that memory retrieval throughout the ﬁrst
part of intermediate memory (ITMA) does not depends on
glycogenolysis, but does so on tests from 40 min on. Eﬀects
occur early and some of the consequences appear during STM,
not ITMA but later during ITMB. However, DAB has eﬀects on
memory beyond this time. When memory is monitored after
injections made 25 min after training, memory loss is seen at the
earliest test made 35 min after training, i.e., 10 min after injection
and with injections 55 min after training, memory is lost 15 min
later – the earliest time tested (Gibbs et al., 2006).
DAB injected into the hippocampus also leads to memory loss
(Gibbs et al., 2008a). However, the pattern of susceptibility in the
hippocampus is not not the same as in IMM (see Figure 3D).
There are three important times where there is coincidence – 5,
25, and 55 min post- training, but there are diﬀerences between
the two brain areas. DAB inhibits in the hippocampus when
injected during ITMA in contrast to IMM, whereas during ITMB
(30–50 min after training) DAB is inhibitory in the cortex but not
in the hippocampus. WhenDAB is injected into the hippocampus
5 min before training, memory is present tested at 20 min
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FIGURE 2 | Glutamate content measured with HPLC in left and right
forebrain hemispheres of chicks before and after training in the
presence of DAB or saline. Chicks were injected with either saline or DAB
5 min before strongly reinforced training and brains rapidly removed 5 min
after training. The increase in glutamate in the left hemisphere is prevented by
DAB. No concomitant decrease occurred in aspartate or
glutamine. #,*P < 0.05. (From Gibbs et al., 2007).
but as with IMM injection memory is absent when chicks are
tested 5 and 120 min after training (Gibbs et al., 2008a). DAB
does not appear to produce a long acting inhibition of glycogen
phosphorylase, since when it is injected 10 min before training it
has no eﬀect onmemory. These data and results mentioned below
suggest that there is a time lag of 5–10 min before glycogenolysis
is signiﬁcantly inhibited.
The breakdown of glycogen is clearly important for learning.
Two of the susceptible periods when long-term memory is
prevented occur when DAB is administered during STM
(0–10 min post-training) or at the end of intermediate memory
(ITMB) 55 min after training, and both periods correlate with
the changes in glycogen levels in the forebrain. However, there
is a second period when memory is sensitive to DAB (around
20–25 min post-training) but is not associated with a signiﬁcant
decrease in glycogen content, suggesting that glycogen synthesis
may be going on at this time, oﬀsetting the inhibitory eﬀect
on glycogenolysis. This is supported by the observation that
an inhibitor of glycogen synthesis inhibits memory 10–20 and
40–60 min after training (see below).
What is the trigger for glycogenolysis? Evidence is presented
here for the involvement of noradrenaline, serotonin and ATP in
the breakdown of glycogen for memory processing.
NORADRENERGIC TRIGGER OF
GLYCOGENOLYSIS
There is evidence that glycogenolysis is stimulated by
noradrenaline (Magistretti, 1988; Quach et al., 1988; Subbarao
and Hertz, 1990), and in the chicken, via the β2 -adrenergic
receptor (Gibbs et al., 2006) at the time of transition between
the ﬁrst and second phases of intermediate memory, i.e., around
25–30 min after training. Noradrenaline acts on two α and three
β receptor subtypes, and in extensive studies we have shown that
it can do so via all ﬁve subtypes (Gibbs and Summers, 2002a,
2005) with eﬀects diﬀerentiated by time and brain location.
Injected into the cortex, noradrenaline promotes formation of
memory after weakly- reinforced training by activation of β2- and
β3-adrenergic receptors as well as by α1-ARs. Consolidation of
weakly reinforced training is achieved with injection of either β2-
(zinterol) or β3-AR (CL316243) receptor agonists (Figure 4A).
Both agonists consolidate when injected at any time up to
30 min after training with the exception of a lesser eﬀect with
injection given at 15 min post-training. In the avian brain
there is a predominance of β2-ARs (see Gibbs et al., 2008a),
whereas in the mammalian brain mainly the β1- subtype of the
receptor is expressed (Quach et al., 1978). However, the β1-
AR agonist RO363 was unable to promote consolidation at any
of the times injected into IMM (Gibbs and Summers, 2002a)
but there are β1- AR eﬀects on memory in other brain areas
such as the Medial Striatum and the hippocampus (see below).
The speciﬁc antagonist for the β2-AR (ICI 118551) and for the
β3-AR (SR59230) both inhibited strongly reinforced learning
when injected 5 min after training, with the β2-AR antagonist
inhibiting up to 25 min after training, i.e., over the duration of
ITMA, but memory was spared when the antagonists were given
5 min before training (Figure 4B).
In the hippocampus injection of the β-AR agonists promoted
consolidation of weakly reinforced training; zinterol and
CL316243 both promoted consolidation although with slightly
diﬀerent timing compared to that seen in the IMM. In
addition, the β1-AR agonist RO363 also promoted consolidation
during STM and the antagonist CGP20712A inhibited strongly
reinforced training over the same time course (Figures 4C,D).
Varying the time of injection clearly shows that both the agonists
and antagonists had diﬀerent memory response patterns in the
hippocampus and the IMM.
Although the β2-AR agonist in IMM can consolidate memory
injected up to 25 min post-training (Figure 4A), the time at
which the antagonist is eﬀective has a close correlation with the
time when DAB is ineﬀective (Figure 3B). In the hippocampus
glycogenolysis is critical for underwriting the STM and ITMA
memory periods as well as at 55 min post-training (Figure 3D).
The β2-AR agonist was only eﬀective for a short time when
injected during ITMA, whereas the β3-ARs were active during
STM and ITMA. The β1-AR agonists promoted consolidation
with injection during STM only (Figure 4C).
Behavioral experiments to conﬁrm that glycogenolysis is
associated with β2-adrenoceptors involved challenging the
selective agonists with a weak dose of DAB or saline. A dose
level of DAB that was not suﬃcient to block memory itself
was injected at a time when it has been shown not to
aﬀect memory. In the cortical area (IMM) β2- and β3-AR
agonists were injected 25 min after weakly reinforced training
when they normally promote consolidation. DAB reduced the
ability of zinterol to consolidate memory (Figure 5A), but
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FIGURE 3 | Glycogen levels after training in chick forebrain and effect on memory consolidation of inhibition of glycogen breakdown. (A) Glycogen
levels in combined left and right hemispheres after training compared with the glycogen content at pre-training. Glycogen was measured as described by Lo et al.
(1970) with minor modifications. Brains were excised and transferred to pre-weighted tubes and their weight determined by the increase in weight. After digestion of
the tissue, glycogen was precipitated by the addition of 95% ethanol, hydrolyzed to glucose in a phenol-sulphuric acid solution and the absorbance measured at
490 nm and calibrated by aid of a standard glucose curve (From O’Dowd et al., 1994; Hertz et al., 2003). (B) Times of injection of DAB into IMM after strongly
reinforced training showing those times at which memory processing requires glycogen breakdown; (C) Times of test after strongly reinforced training following DAB
injection 5 min before training revealing when memory is affected by DAB; (D) Times of injection of DAB into the hippocampus following strongly reinforced training.
(From Gibbs et al., 2007, 2008b). In this figure and all subsequent graphs the dashed line represents saline control value for strongly reinforced training (high DR) or
weakly reinforced training (DR approaching 0.5) *P < 0.05.
had no eﬀect on the ability of the CL316243 to consolidate
memory (Figure 5B). In the hippocampus, a low dose of
DAB did not aﬀect the ability of CL316243 or the β1-AR
agonist RO363 to consolidate memory, but as in IMM, DAB
reduced the ability of zinterol to promote consolidation (Gibbs
et al., 2008a). Since DAB prevents activation-induced glycogen
breakdown and decreases memory, we conclude that glycogen
breakdown achieved by stimulation of β2-ARs is necessary for
memory.
GLYCOGEN CONTENT AND SYNTHESIS
IN CULTURED CHICKEN ASTROCYTES
The eﬀects on glycogen levels measured in chick astrocyte
primary cultures, in the presence of DAB or in the presence
of zinterol (with DAB or saline added 20 min prior to zinterol
exposure) are shown in Figure 6A. As can be seen DAB did not
alter the basal glycogen levels but it did prevent the zinterol-
induced decrease in glycogen level (Gibbs et al., 2006) but had no
signiﬁcant eﬀect in the presence of the β3-adrenergic antagonist
CL316243.
If stimulation of noradrenergic β2-ARs stimulates memory
consolidation via the breakdown of glycogen with no dramatic
decrease in glycogen levels (at 30 min post-training), it is
likely that there is some cellular mechanism to stimulate the
synthesis of glycogen. This increased synthesis is achieved by
noradrenaline released from neurons stimulating astrocytic α2-
ARs (post-junctional receptors; Hertz et al., 2007; Hutchinson
et al., 2011; Gibbs and Hutchinson, 2012). At the same time β3-
adrenergic stimulation increased uptake of glucose, securing the
glucose presence needed for the synthesis of glycogen (Gibbs and
Summers, 2002a,b; Gibbs et al., 2008c).
Noradrenaline increased glycogen formation (total 14C
incorporation) in astrocytic culture (Hutchinson et al., 2008,
2011). This was not inhibited by the β1-/β2-AR antagonist
propranolol nor by the β3-AR antagonist SR59230A, suggesting
that the eﬀect of noradrenaline to increase glycogen turnover
is not mediated by β-ARs (Hutchinson et al., 2011). Insulin
was used as the positive control (Figure 6B). When the eﬀects
on glycogen levels were compared, insulin and clonidine
signiﬁcantly increased glycogen levels but the other agonists
had no eﬀect (Figure 6C). A timecourse experiment with
noradrenaline, isoprenaline and zinterol demonstrated
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FIGURE 4 | Involvement of β-adrenoceptors in weakly- and strongly reinforced memory in both avian cortex (IMM) and hippocampus. Injections of
selective β-AR agonists at different times after weakly reinforced training in IMM (A) or hippocampus (C) and of selective antagonists for β-ARs in IMM (B) or
hippocampus (D) after strongly reinforced learning. Memory tested 120 min after training. (From Gibbs, 2008).
signiﬁcantly decreased glycogen levels following 5 and 10 min
of stimulation (Hutchinson et al., 2008). In experiments where
noradrenaline and subtype selective agonists were incubated with
astrocytes, only noradrenaline and the α2-AR agonist clonidine
increased glycogen synthesis measured as total 14C incorporation
(% of basal) into glycogen, whereas the β-AR agonists had no
signiﬁcant eﬀect. Noradrenaline stimulates glycogenolysis and
formation of cAMP in similar cultures of astrocytes (O’Dowd
et al., 1995), consistent with the glycogenolytic mechanism
shown in Figure 7A.
The α2-AR agonist clonidine activates both α2A- and α2C-
ARs and both are present in areas of the brain important
for memory processing (Scheinin et al., 1994; Hutchinson
et al., 2011). AR α2A-and α2C-AR subtypes are found both pre
and post-synaptically on neurons as well as post-junctionally
on astrocytes (Enkvist et al., 1989; Aoki, 1992; Lee et al.,
1998a,b; Hertz et al., 2010). In chick astrocytes clonidine
stimulation of glycogen synthesis was blocked by the α2C-
AR subtype selective agonist ARC239 (Gibbs and Hutchinson,
2012). α2-Adrenergic stimulation activates glycogen synthesis
by stimulation of the AKT pathway and subsequent down-
regulation of GSK (Figure 7B). This is consistent with the
FIGURE 5 | Functional selectivity of drug interaction. (A) Consolidation
of memory for weakly reinforced training with the β2-AR agonist zinterol or (B)
the β3-AR agonist CL316243, challenged by preadministration at 20 min of a
suboptimal dose of DAB. Zinterol in the presence of DAB, inhibiting the
breakdown of glycogen, was less effective in promoting memory
consolidation. (From Gibbs et al., 2008c).
observations that the potent α2-AR agonist, dexmedetomidine
induces ERK phosphorylation both in cultured astrocytes and in
brain slices, but not in cultured neurons (Li et al., 2008; Du et al.,
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FIGURE 6 | The effect of adrenoceptor agonists on glycogen levels turnover and new synthesis in cultured astrocytes from chick forebrain.
(A) Astrocytes were incubated for 2 h under basal conditions with no drug added, or for 2 h in the presence of zinterol or CL316243. DAB was added 20 min
prior to the 2 h incubation (adapted from from Gibbs et al., 2006). (B) Glycogen synthesis assessed by [14C]-glucose incorporation into glycogen in response to
3 hr stimulation with AR agonists, noradrenaline or insulin. (C) Glycogen levels expressed as % of basal after incubation with AR agonists or insulin. *P < 0.05;
**P < 0.001. (From Hutchinson et al., 2011).
2009), and that the ERK and AKT pathways interact in astrocytes
(Dai et al., 2013).
EFFECT OF ARC239 INHIBITION OF α2C
ARS ON MEMORY PROCESSING AND
COMPARISON WITH DAB TIMECOURSE
Inhibition of the synthesis of new glycogen, caused by injection
of the selective α2C-AR antagonist ARC239 into IMM revealed
a clear time-dependence. Memory at 120 min was inhibited
by ARC239 injected at two time periods after training, (i)
when injected 10–20 and (ii) when injected 40–50 min after
strongly reinforced training (Figure 8A). On the other hand,
preventing glycogen breakdown with DAB, inhibited memory
when injected at three diﬀerent times: 5 min before, 25–35 min
after and at 55 min after training in IMM. The eﬀects of ARC239
and DAB mirror each other but with a lag time of about
10 min (Hertz and Gibbs, 2009). ARC239 prevented memory
at quite discrete time points, which suggests that its inhibitory
action is not sustained for long periods in the brain. In the
presence of ARC239 there is insuﬃcient accessible glycogen,
so β2-ARs although activated cannot induce glycogenolysis and
promote consolidation. Since noradrenaline will activate α2-AR
as well as β2-ARs at the same time, any measurement of
glycogen levels will reﬂect the net balance between synthesis and
degradation.
There is a slow turnover of glycogen during resting conditions
in the brain (Brown, 2004; Oz et al., 2007), but it can
obviously be accelerated to underwrite memory processing in
the hippocampus and cortex, as illustrated in Figure 3. DAB
is only active in the brain for a short time period as when
injected 10 min before training DAB had no eﬀect on memory.
In agreement with this idea, DAB injected 5 min prior to training
memory is only shown to be eﬀective when ﬁrst tested 5 min after
training, suggesting that it does not remain active in the brain
for long and therefore only acts on memory processes very close
to the time of injection, even though the consequences appear
later.
Our data clearly show that glycogen has an active role in
astrocytic function. This may in turn also inﬂuence neuronal
metabolism because glycogenolysis may inhibit astrocytic glucose
consumption and thereby make more glucose available for
neurons (DiNuzzo et al., 2012, 2015). Since glycogen turnover
is slow under resting conditions, the question arises as to how
fast it can be recruited in cells and are there readily accessible
stores with fast turnover in brain regions important for memory.
It is possible that high turnover could occur in speciﬁc brain
regions during neural activation. Glycogen phosphorylase can
be activated within seconds and is stimulated during various
behavioral activities (Walling et al., 2006). In chick astrocyte
cultures, we have shown an initial decrease in glycogen levels
after 5–10 min of incubation with noradrenaline, this decrease
is then followed by an increase in glycogen levels (Hutchinson
et al., 2011). The fall in glycogen levels, but not the later increase,
also occurs with incubation with zinterol. These biochemical
results suggest that the onset of breakdown of glycogen can occur
quickly.
We designed experiments where the glycogen synthesis
inhibitor ARC239 was challenged with zinterol (increasing
glycogenolysis and promoting weakly reinforced learning) in two
diﬀerent paradigms (Gibbs and Hutchinson, 2012; Figures 8B,C)
to ask two questions: ﬁrstly, can prevention of glycogen re-
synthesis reduce glycogen levels suﬃciently so that zinterol is
unable to promote weakly reinforced learning, and at when does
this occur after training? When we prevented glycogen synthesis
by injecting ARC239, given 5 min before training, zinterol was
able to promote consolidation given either immediately or 5 min
after training, but it was unable to promote memory when given
later than this, at 10, 15, or 20 min after training (Figure 8B),
although zinterol will normally do so at these times. These
results suggest that the ARC239-mediated inhibition following its
injection 5 min before training took 10 min to reduce the readily
available glycogen stores.
Secondly, we asked by what mechanisms and at what times
can inhibition of glycogen synthesis aﬀect the ability of zinterol to
promote consolidation after weakly reinforced training? Zinterol
was injected 20 min after training to promote consolidation
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FIGURE 7 | Noradrenergic signaling stimulating glycogenolysis (A) or glycogen synthesis (B). (A) β2-Adrenergic Gs-mediated formation of cAMP and
phosphorylation of proteinkinase A (PKA) leads to conversion (phosphorylation ) of phosphorylase b to the active phosphorylase a, which stimulates glycogen
breakdown (conversion of glycogen to glucose-1-phosphate). (B) α2-Adrenergic Gi-mediated stimulation of the PI3K-AKT pathway leads to phosphorylation of
glycogen synthase kinase (GSK) and dephosphorylation of glycogen synthase, which stimulates glycogen synthesis (incorporation of UDPglucose into glycogen).
and ARC239 at times between 5 min before and 15 min after
training (i.e., 20–5 min before zinterol) prevented the β2-AR
agonist promoting consolidation at all times except 5 min before
training (Figure 8C). ARC239 given up to 10 min before zinterol
prevented it from promoting consolidation. These results again
suggest that depletion of accessible glycogen stores takes place
quickly, i.e., within 10 min of injection.
Serotonin and Glycogenolysis
Serotonin is another neuromodulatory transmitter that
promotes memory consolidation (Gibbs and Hertz, 2014).
Like noradrenaline, serotonin activates glycogenolysis in brain
tissue and in astrocytes (Quach et al., 1982; Cambray-Deakin
et al., 1988; Magistretti, 1988; Chen et al., 1995; Kong et al., 2002;
Darvesh and Gudelsky, 2003). Although the β2-AR activation
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FIGURE 8 | Effect of inhibition of glycogen re-synthesis by the α2B/C-AR antagonist ARC239 on strongly reinforced memory and challenges to
inhibition of re-synthesis by β2-AR stimulation (glycogen breakdown) and vice versa. (A) ARC239 was injected into IMM at different times after training. The
timing of the effect of ARC239 is compared with that of DAB (From Gibbs et al., 2008b; Hertz and Gibbs, 2009). (B) ARC239 or saline were injected 5 min before
weakly reinforced training and zinterol injected into different groups at various times after training. Inhibiting re-synthesis of glycogen prevented β2-AR stimulation
from promoting memory consolidation up to 10 min prior to zinterol injection. Normal learning is indicated by black squares. (C) Zinterol was injected into all groups
20 min after weakly reinforced training and ARC239 had been injected at times from 25 to 5 min before zinterol (i.e., from 5 min before to 15 min after training).
*P < 0.05. (From Gibbs and Hutchinson, 2012).
FIGURE 9 | Effect of the selective 5-HT2B/C receptor antagonist SB221284 on strongly reinforced memory. (A) Time of injection of SB221284 following
strongly reinforced training. (B) Ability of the inhibitor DAB to prevent consolidation of weakly reinforced memory. A suboptimal dose of DAB was given either before
or 15 min after training, serotonin was given 2.5 or 20 min after training. DAB only interfered with serotonin induced consolidation at the early period. *P < 0.05.
(From Gibbs and Hertz, 2014).
appears to be the signal leading to the second glycogenolytic
period in IMM, noradrenaline is not implicated in the ﬁrst period
close to training. Serotonin has eﬀects on memory in the chick
dependent on the dose. Low doses of serotonin promote memory
consolidation when injected up to 25 min after weakly reinforced
training whereas high doses inhibit memory (Gibbs and Hertz,
2014). Serotonin thus appears to act on at least two diﬀerent 5HT
receptors during learning stimulating a high aﬃnity serotonin
receptor, identiﬁed below as the 5HT2B receptor and inhibiting a
lower-aﬃnity serotonin receptor, possibly a 5-HT1 receptor.
Strongly reinforced memory is inhibited by the selective
5HT2B,C antagonist SB221284 injected immediately, 2.5 or
25 min after (Figure 9A). Conversely, weakly reinforced learning
can be rescued by administration of serotonin (Figure 9B). In
contrast to the β2-AR involvement, it is only during the ﬁrst
period where SB221284 inhibits (2.5 min after training) that
the rescue by serotonin is challenged by a sub-optimal dose of
DAB. In contrast, during the second glycogenolytic period where
serotonin plays only a minor role, memory is not signiﬁcantly
aﬀected when DAB is administered together with serotonin
(Figure 9B). On the other hand the 5-HT2B agonists ﬂuoxetine
and paroxetine (Li et al., 2008; Diaz et al., 2012) can consolidate
weakly reinforced learning. It is interesting that ﬂuoxetine
and paroxetine which are better known as serotonin-speciﬁc
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antidepressants (SSRIs) also consolidate weakly reinforced
learning in the chicken (Gibbs and Hertz, 2014). Fluoxetine also
increases glycogenolysis in cultured astrocytes (Chen et al., 1995)
by a 5-HT2B receptor-mediated eﬀect (Kong et al., 2002).
ATP AND GLYCOGENOLYSIS
As with the neurotransmitters, noradrenaline and serotonin,
memory consolidation is also modulated by endogenous
adenosine triphosphate (ATP) acting at purinergic receptors in
the hippocampus (Gibbs et al., 2011) and in the cortex (IMM;
Cronin et al., 2011). ATP is important for communication
between neuronal and glial circuits and is released from both
neurons and astrocytes (Fields and Burnstock, 2006; North and
Verkhratsky, 2006). ATP released from astrocytes acts as a
widespread gliotransmitter, triggering, and maintaining calcium
signaling and calcium oscillations (Bowser and Khakh, 2004;
Burnstock, 2007; Zorec et al., 2012). Release of transmitter
ATP from cultured astrocytes is inhibited by DAB (Hertz
et al., 2014b; Xu et al., 2014). On the other hand ATP is
also known to trigger glycogenolysis (Hertz et al., 2015c). ATP
injected into either the hippocampus (Figure 10A) or IMM
promoted consolidation of weakly reinforced training at two
time periods: 0–2.5 and 25–30 min post-training. The two non-
hydrolyzable agonist analogs, ATPγS and ADPβS (Figure 10B)
produced similar but not identical eﬀects on memory time
courses, in particular with ADPβS promoting consolidation at
35 but not at 30 min, whereas ATPγS promoted consolidation
when injected at 30 but not at 35 min. Challenge to the
action of ADPβS by the selective ADPβS antagonist MRS2179
showed that it acts via purinergic P2Y1 receptors (Gibbs et al.,
2011).
Astrocytes are a major source of the released ATP in
hippocampal slices in rodents (Bowser and Khakh, 2007),
and evidence suggesting astrocytes are the source of the ATP
promoting memory comes from the eﬀect of thrombin on
memory processing. Thrombin selectively activates calcium
release from intracellular stores in astrocytes (Bowser and Khakh,
2004) and thrombin injected into IMM (Gibbs and Bowser,
2010) or the hippocampus (Figure 10C; Gibbs et al., 2011)
like ADPβS, promoted memory consolidation when injected at
2.5 and 35 min after training. These results strongly suggest
that astrocytes are the source of the ATP facilitating memory.
Thrombin consolidation could also be successfully challenged by
a low dose of the P2Y1 antagonist MRS2179. The inhibitory eﬀect
of ﬂuoroacetate, which inhibits astrocytic oxidative metabolism,
also conﬁrms astrocytic involvement in promotion of memory
by ATP (Gibbs and Bowser, 2009). Neither ADPβS nor thrombin
were able to promote consolidation with prior administration of
ﬂuoroactate (Gibbs et al., 2011).
Further support for astrocytic involvement in purinergic
memory formation comes from the successful challenge by
DAB of both ADPβS and thrombin rescue of weakly reinforced
learning (Figures 10D,E). DAB did not challenge ATPγS
suggesting that the source of the ATP mimicked by ATPγS
could therefore be neurons, which co-release ATPwith glutamate
or noradrenaline (Burnstock, 2007). Incubation of astrocytes
with ATPγS or ADPβS resulted in an increase in intracellular
calcium [Ca2+]i, with the eﬀect of ADPβS being blocked by
ﬂuoroacetate and also by the P2Y1 antagonist, again implicating
a speciﬁc role for astrocytic P2Y1 receptors in the calcium
response. We suggested that the source of the ATP itself acting on
neural P2Y1 receptors is most likely astrocytes, since thrombin
selectively increases [Ca2+]i in astrocytes but not in neurons
(Bowser and Khakh, 2004). Astrocytic [Ca2+]i must accordingly
play an important role in the consolidation of short-term
to long-term memory through activation of astrocytic P2Y1
receptors (Gibbs et al., 2011). An increase in [Ca2+]i is also
a prerequisite for stimulation of glycogenolysis (Hertz et al.,
2015c). An important pathway for entry of Ca2+ is store-operated
Ca2+ channels, and store-operated Ca2+ entry (SOCE) triggers
astrocytic glycogenolysis in cortical astrocyte cultures (Müller
et al., 2014). Accordingly administration of DAB reduces the
amount of Ca2+ loaded into the sarco/endoplasmic reticulum.
GLYCOGEN FACILITATION OF DE NOVO




It was shown earlier (Figure 2) that glycogenolysis is essential
for the production of glutamate and thus also of its metabolite
GABA, two important neurotransmitters. Glutamate is supplied
by astrocytes to neurons, which are unable to synthesize
glutamate de novo as will be discussed below. If the breakdown
of glycogen in astrocytes is compromised, then so is neural
transmission (Hertz et al., 2003; Hertz and Zielke, 2004;
Sickmann et al., 2009). This process would require relatively rapid
turnover of glycogen in vivo.
Astrocytic glycogenolysis supports increased glutamate and
glutamine synthesis at both 5 min (Figure 2; Hertz et al., 2003;
Gibbs et al., 2007) and probably also after 30 min after training.
Both these times are consistent with the times at which glutamate
is released in trained chickens (Daisley et al., 1998; Daisley
and Rose, 2002). The reduction in glycogen levels in the chick
forebrain coincides with a transient increase in glutamate in the
left forebrain over the ﬁrst 5 min after training, and since there is
no concomitant decrease in aspartate or the glutamate precursor
glutamine, it indicates de novo synthesis of glutamate (Hertz et al.,
2003; Gibbs et al., 2007). The importance of glycogenolysis for
glutamate synthesis has been conﬁrmed in the rat (Sickmann
et al., 2012).
Since glycogen is responsible for the increased glutamate
content in neurons occurring at speciﬁc times during memory
consolidation, it would be expected that glutamine as a glutamate
precursor should be able to rescue memory impairment caused
by DAB. Our data show that glutamine can indeed rescue
DAB-impaired memory when administered up to 2.5 min after
training as well as during the second window for rescue 30–
55 min after training. At times when DAB does not inhibit,
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FIGURE 10 | Effect of hippocampal injection of ATP, ATPγS, ADPβS, or thrombin (A–C) on consolidation of weakly reinforced training and the effect of
DAB on the ability of thrombin, ADPβS to promote consolidation (D,E). Injections over two time periods after weakly reinforced training resulted in
consolidation of memory 120 min after training. (A) ATP, (B) ADPβS and ATPγS and (C) thrombin. (D,E) A sub-optimal dose of DAB (red columns) was injected
subcutaneously 5 min before weakly reinforced training or 5 min before injection of thrombin or ADPβS into the hippocampus 2.5 or 35 min after weakly reinforced
training, i.e., at times when they normally promote consolidation (open columns). *P < 0.05. (From Gibbs et al., 2011).
i.e., when glycogen breakdown is not critical for memory
consolidation (5–25 min) post-training glutamine does not
rescue (Figure 11A) even though glutamine enhances weakly
reinforced learning over this time period (5–30 min; Gibbs et al.,
2006, 2007, 2008b). Additional experiments have shown that
DAB is not successfully challenged by either aspartate or the
astrocyte-speciﬁc metabolic substrate acetate alone. However,
DAB-induced memory impairment can be rescued by acetate
together with aspartate, with acetate needed as a precursor for the
pyruvate carboxylase product oxaloacetate, because acetate alone
cannot support pyruvate carboxylation (Gibbs et al., 2008b).
These results suggest that a major function for glycogen during
memory consolidation is to enable synthesis of glutamate and
GABA via glutamate production in the astrocytes. This does
not preclude that glycogen might also have a major role as
a substrate for energy production. Moreover, both glutamate
synthesis and its degradation are oxidative processes resulting
in ATP production (Hertz et al., 2007). However, the relatively
low rates of glycogenolysis in brain (Oz et al., 2012) should
be kept in mind. Even the fast decline in glycogen occurring
in the chick brain soon after training (Hertz et al., 2003) only
amounts to ∼1.0 μmol/min per g wet wt, which is similar to
the stimulated rate of glucose utilization in rat brain (Hertz
and Dienel, 2002). A major role for glycogen might also be to
support the energetic needs of astrocytes, including those related
to their signaling (DiNuzzo et al., 2012; Xu et al., 2013). If the role
of extracellular lactate is, indeed, a signaling one (as suggested
above), then glycogenolysis might also promote signaling to
neurons.
Lactate also rescues DAB induced impairment of memory
when injected either immediately after training or 10–20 min
later (Figure 11B). So, in contrast to the action of glutamine,
lactate rescues memory from loss caused by DAB only at times
when memory is NOT susceptible to DAB. These are the
same time periods over which lactate normally enhances weakly
reinforced learning (5–20 min; Gibbs et al., 2008b). Because of
the diﬀerence in timing of the eﬀect of lactate and glutamine,
it is unlikely that they are producing the same end result of
increasing glutamate. Lactate is readily taken up by neurons and
astrocytes, but lactate uptake into astrocytes inhibits glycolysis
(Hertz et al., 2014a). In that paper we discussed the ﬂuxes of
lactate into astrocytes, neurons, and between astrocytes and the
multifunctional roles for lactate. Transport of lactate between
brain cells is mainly between astrocytes via gap junctions and
release into extracellular space leads to signiﬁcant exit of lactate
from the brain via the blood and via the perivascular-lymphatic
drainage system (Ball et al., 2010).
Many years agowe found evidence that inhibition of the Na,K-
ATPase abolished memory (Mark and Watts, 1971; Gibbs and
Ng, 1977). Recent experiments have suggested that β2-adrenergic
activity may partly alleviate the impaired memory in day-old
chickens resulting from Na,K-ATPase inhibition (Hertz et al.,
2015b). This would suggest involvement of the astrocytic Na,K-
ATPase, which may require glycogenolysis for its function
(DiNuzzo et al., 2010; Xu et al., 2013; Hertz et al., 2015b).
Clearance of extracellular K+ increases signal to noise ratio and
thus is likely to play an important role in synaptic plasticity (and
hence in triggering memory formation).
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FIGURE 11 | Ability of glutamine or lactate to rescue memory following DAB inhibition of glycogenolysis (A,B) and effect of hippocampal
injection of antagonists of NMDA receptors, GABAB receptors or fluoroacetate on strongly reinforced training (C,D). DAB was injected into IMM
5 min before strongly reinforced training and challenged at various times by glutamine (A) or L-lactate (B) (From Hertz and Gibbs, 2009). (C) The NMDA
angtagonist D-APV injected into the hippocampus inhibited memory given up to 5 min post-training and again when given 27.5–32.5 min post-training.
(D) Both the GABAB receptor antagonist, phaclofen and fluoroacetate inhibited memory when given between 2.5 and 25 min post-training. *P < 0.05.
(From Gibbs et al., 2008a; Gibbs and Bowser, 2009).
GLYCOGEN AS THE SUBSTRATE FOR
DE NOVO SYNTHESIS OF GLUTAMATE
AND GABA
Both glutamate and GABA are involved in neurotransmission in
the central nervous system and roles for glutamatergic NMDA
(Figure 11C) and AMPA receptors (Gibbs et al., 2008a), mGluR
and GABAB (Gibbs and Bowser, 2009) receptors have been
described for memory processing in the chick hippocampus. The
importance of glutamate in memory formation up to 30 min
post-training is highlighted by its eﬀects at the two time periods
0–2.5 and 25–30min, i.e., during STM and at the ITM transition
from ITMA to ITMB. ATP and thrombin are similarly involved
at these two times (Gibbs et al., 2011). A recent report has
shown that DAB inhibition of glycogenolysis prevents LTP
beyond 30 min in the rat hippocampus (Suzuki et al., 2011). We
have shown above that one important reason why consolidation
of memory is dependent on glycogenolysis is because of the
brain’s requirement for glutamate formation. However, both
ﬂuoroacetate (Figure 11D) and DAB (Figure 3D) injected into
the hippocampus impair memory when given in between these
times, implicating astrocytic activity and glycogenolysis over this
period. The involvement of glycogen breakdown in memory
is more extensive in the hippocampus than in the cortical
IMM, and this may reﬂect on the requirement for astrocytes
to supply GABA for interneurons. It is of interest that in
IMM, ﬂuoroacetate loses its inhibitory eﬀect earlier than in the
hippocampus and by 10 min after training it is ineﬀective in
disrupting memory (Gibbs and Ng, 1977). GABA produced from
glutamate is also dependent on glycogenolysis and inhibition of
GABAB receptors by the selective antagonist phaclofen resulted
inmemory inhibition injected at all times between 2.5 and 25min
after training (Figure 11D; Gibbs and Bowser, 2009).
WHY ASTROCYTES ARE REQUIRED
FOR GLUTAMATE SYNTHESIS
The reason neurons are unable to synthetize glutamate (and thus
also GABA) and therefore are dependent upon glycogenolysis-
mediated glutamate synthesis is that they lack an enzyme,
pyruvate carboxylase, which is present in astrocytes (Yu et al.,
1983; Shank et al., 1985) and most cell types outside the brain.
Pyruvate carboxylase activity is required for direct conversion of
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FIGURE 12 | Cartoon showing key features of glucose metabolism in
neurons (N and green) and astrocytes (A and red) and interactions
between the two cell types. Three reactions of importance in the present
review are astrocyte-specific: (1) glycogenolysis (and thus its stimulation by
noradrenergic, serotonergic and purinergic subtype-specific agonists); (2)
formation of the tricarboxylic acid (TCA) cycle intermediate oxaloacetate (OAA)
by condensation of pyruvate with CO2 (pyruvate carboxylation); and (3)
formation of glutamine from glutamate by glutamine synthetase. Reaction (1)
is important for the transmitter actions on memory and for glutamate synthesis
documented in this review, and for partial alleviation by β2-adrenergic activity
of DAB-impaired memory resulting from Na,K-ATPase inhibition and inhibition
of release of gliotransmitter ATP and of SOCE by DAB referred to. It is also
important for release of lactate acting on neurons. Reaction (2) is essential for
creation of a new molecule of a TCA cycle constituent OAA, allowing another
molecule of a TCA cycle constituent, α-KG to leave the cycle and form
glutamate. *Indicates the importance of glycogenolysis for glutamate
synthesis and glutamate synthesis from α-KG. And reaction (3) is a crucial
step in supplying neurons with both newly synthesized and previously
released glutamate. A fourth astrocyte-specific reaction is conversion of
malate to pyruvate after its exit from the TCA cycle. This reaction allows
metabolic degradation of accumulated glutamate but is not discussed in the
review. The Figure should not give the impression that one half of brain energy
metabolism is neuronal and one half astrocytic. Astrocytes account for a
smaller fraction of the volume and therefore only for about one quarter of total
glucose metabolism in gray matter (reviewed by Hertz, 2011), and other cell
types like microglia also contribute to total energy metabolism.
pyruvate to oxaloacetate (OAA), which in turn is needed for the
astrocytic production of glutamate (Figure 12). Metabolism of
pyruvate by the pathway via acetyl coenzyme A (ac.CoA) which
is used for energy production does not allow production of a
new tricarboxylic acid (TCA) constituent because the two carbon
atoms which are introduced into the TCA cycle with ac.CoA are
released (providing energy) during its subsequent turn to OAA.
Such a new molecule of a TCA cycle constituent is necessary for
glutamate formation because glutamate is formed from another
TCA cycle constituent, α-ketoglutarate, α-KG, which accordingly
is removed from the cycle.
After its formation in astrocytes glutamate is converted
by the astrocyte-speciﬁc glutamine synthetase (Norenberg and
Martinez-Hernandez, 1979; Anlauf and Derouiche, 2013) to
glutamine which is released from astrocytes and accumulated
into neurons by speciﬁc, regulated transporters (Nissen-Meyer
and Chaudhry, 2013) in the glutamine-glutamate cycle (gln-
glu cycle) and re-converted to glutamate and GABA (with
slightly diﬀerent pathways used in glutamatergic and GABA-
ergic neurons). It should be emphasized that not all transmitter
release depends on the de novo synthesis, since the transmitters
are also re-utilized. However, especially glutamate is accumulated
into astrocytes, not the neurons from which it was released, and
again transferred to neurons after conversion to glutamine in
astrocytes. This process accounts for ∼75% of the ﬂux in the
gln-glu cycle whereas the remaining ∼25% represents de novo
synthesis (reviewed by Gibbs et al., 2008b; Hertz, 2013; Hertz and
Rothman, 2015).
The similarly astrocyte-speciﬁc glycogenolysis (Pfeiﬀer-
Guglielmi et al., 2003) is also shown in Figure 12, and its
correlation with glutamine synthesis indicated by asterisks,
although it is probably not glutamate formation from α-KG
but rather pyruvate carboxylation that requires glycogenolysis.
This review has documented the importance of glycogenolysis
for both glutamate formation and Na,K-ATPase activity and
references have been made to its importance for release of
gliotransmitter ATP and for supply of intracellular Ca2+ by
store-operated Ca2+ entry (SOCE). Similarly, the possibility that
glycogen-derived lactate may be an important signal to neurons
has been discussed. Figure 12 summarizes these mechanisms
(red text) as well as stimulation of glycogenolysis by β2-AR,
5-HT2B receptors and P2Y1 receptors and of glycogen synthesis
by α2AR, all documented in the review.
CONCLUDING REMARKS
The excitatory and inhibitory neurotransmitters, glutamate, and
GABA, are mainly responsible for information transfer and
communication between nerve cells, but it is the modulation of
synaptic activity by neurotransmitters including noradrenaline,
serotonin and ATP that determines whether information
in short-term or intermediate memory is consolidated into
permanent storage or allowed to fade. These neuromodulatory
transmitters act via astrocytes, stimulating the breakdown of
glycogen that enables the synthesis of glutamate and glutamine
that is essential for maintaining normal neuronal levels of
glutamate and GABA and also for the regulation of potassium
homeostasis (Hertz et al., 2015a).
Serotonin is responsible for the glycogen breakdown required
for the transition from STM to ITM 2.5 min after training and
noradrenaline for the transition from intermediate to long-term
memory 30 min after training. Even if glycogen’s major role
should be to provide energy, it clearly has another role in the
brain where it is responsible for the synthesis of glutamine, the
precursor for glutamate in neurons that are unable to synthesize
glutamate de novo and most likely also for astrocytic K+ uptake
(Xu et al., 2013; Hertz et al., 2015a), which constitutes an essential
component of K+ homeostasis in the brain.
All noradrenergic input into the forebrain comes from cell
bodies located in the locus coeruleus situated in the medulla.
These ﬁbres radiate out to brain areas including the hippocampus
and the cortex where noradrenaline released acts on the
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noradrenergic receptors located on neurons, astrocytes, and
microvessels and therefore can inﬂuence memory (Gibbs et al.,
2010). The eﬀect of noradrenaline on diﬀerent cell types depends
on the location of the diﬀerent adrenergic receptors. The eﬀects of
noradrenergic stimulation on astrocytes, neurons and microglia,
has been reviewed recently by O’Donnell et al. (2012).
In the avian cortex and hippocampus acts released
noradrenaline acts on both β2 and α2 adrenergic receptors
to cause the breakdown and the re-synthesis of glycogen. It
promotes the transition of intermediate to long-term memory,
whereas serotonin-induced glycogenolysis is responsible for
the earlier consolidation of STM to intermediate memory,
probably without any concomitant eﬀect of serotonin on
glycogen re-synthesis. This might explain why the level of
glycogen is reduced 5 min after training (when serotonin
mediates glycogenolysis) but not 30 min after training, when
noradrenaline mediates glycogenolysis as well as glycogen
synthesis (Figure 3A).
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